DXC Technology uses generative AI to process complex documents more efficiently, reducing human errors and cutting manual tasks by up to 60%
Each new drug approval requires more than 500 hours of manual labor to create and maintain thousands of documents. Generative AI can reduce effort by up to 60%. With 37,000 drug trials each year, the anticipated industry savings could exceed $1.4 billion.
DXC helped its pharmaceutical client automate document search and summarization using a variety of AWS tools, including the Hugging Face FLAN-T5 model in Amazon SageMaker to summarize documents, the Anthropic Claude 2 model in Amazon Bedrock to refine prompts, Amazon CodeWhisperer to generate lambda code for API calls, and Amazon Kendra for enterprise search.